Epigenetics in thyroid cancer: a bibliometric analysis

被引:0
|
作者
Li, Hui [1 ]
Wu, Peng [1 ]
机构
[1] Cent South Univ, Xiangya Sch Med, Dept Thyroid Surg, Affiliated Canc Hosp,Hon Canc Hosp, Changsha, Hunan, Peoples R China
关键词
bibliometric analysis; CiteSpace; epigenetics; thyroid cancer; VOSviewer; COLORECTAL-CANCER; TUMOR-GROWTH; METHYLATION; INHIBITOR; HYPERMETHYLATION; PATTERNS; TRENDS; ACID; GENE; TOOL;
D O I
10.1530/EC-24-0087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Epigenetics, which involves regulatory modifications that do not alter the DNA sequence itself, is crucial in the development and progression of thyroid cancer. This study aims to provide a comprehensive analysis of the epigenetic research landscape in thyroid cancer, highlighting current trends, major research areas, and potential future directions. Methods: A bibliometric analysis was performed using data from the Web of Science Core Collection (WOSCC) up to 1 November 2023. Analytical tools such as VOSviewer, CiteSpace, and the R package 'bibliometrix' were employed for comprehensive data analysis and visualization. This process identified principal research themes, along with influential authors, institutions, and countries contributing to the field. Results: The analysis reveals a marked increase in thyroid cancer epigenetics research over the past two decades. Emergent key themes include the exploration of molecular mechanisms and biomarkers, various subtypes of thyroid cancer, implications for therapeutic interventions, advancements in technologies and methodologies, and the scope of translational research. Research hotspots within these themes highlight intensive areas of study and the potential for significant breakthroughs. Conclusion: This study presents an in-depth overview of the current state of epigenetics in thyroid cancer research. It underscores the potential of epigenetic strategies as viable therapeutic options and provides valuable insights for researchers and clinicians in advancing the understanding and treatment of this complex disease. Future research is vital to fully leverage the therapeutic possibilities offered by epigenetics in the management of thyroid cancer.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Epigenetics in cancer
    Sharma, Shikhar
    Kelly, Theresa K.
    Jones, Peter A.
    CARCINOGENESIS, 2010, 31 (01) : 27 - 36
  • [42] Epigenetics and cancer
    Kanwal, Rajnee
    Gupta, Sanjay
    JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (02) : 598 - 605
  • [43] Cancer Epigenetics
    Ahmad, Aamir
    CURRENT CANCER DRUG TARGETS, 2018, 18 (01) : 3 - 4
  • [44] Epigenetics and cancer
    Verma, M
    Maruvada, P
    Srivastava, S
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (5-6) : 585 - 607
  • [45] cancer epigenetics
    Aburatani, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 425 - 425
  • [46] Epigenetics and cancer
    Deltour, S
    Chopin, V
    Leprince, D
    M S-MEDECINE SCIENCES, 2005, 21 (04): : 405 - 411
  • [47] Cancer Epigenetics
    Weber, Wendell
    MOLECULAR BIOLOGY OF CANCER: TRANSLATION TO THE CLINIC, 2010, 95 : 299 - 349
  • [48] Epigenetics and cancer
    Baylin, Stephen A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [49] Epigenetics and cancer
    Lund, AH
    van Lohuizen, M
    GENES & DEVELOPMENT, 2004, 18 (19) : 2315 - 2335
  • [50] Cancer and Epigenetics
    Bae, Jae-Bum
    Kim, Young-Joon
    ANIMAL CELLS AND SYSTEMS, 2008, 12 (03) : 117 - 125